Pharma Mar, S.A. (BME:PHM)
Spain flag Spain · Delayed Price · Currency is EUR
66.60
-0.65 (-0.97%)
Nov 16, 2026, 5:35 PM CET

Pharma Mar Balance Sheet

Millions EUR. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
44.5617.8263.2460.02149.81113.35
Short-Term Investments
131.73149.4191.29102.5432.6188.53
Cash & Short-Term Investments
176.29167.22154.53162.56182.42201.88
Cash Growth
20.20%8.22%-4.94%-10.89%-9.64%3.26%
Accounts Receivable
53.7239.0534.2727.229.3250.91
Other Receivables
-0.360.410.35--
Receivables
53.7239.4134.6827.5529.3250.91
Inventory
53.1450.6450.8939.2927.7510.54
Prepaid Expenses
2.011.51.742.925.983.91
Other Current Assets
10.424.658.4120.2829.7128
Total Current Assets
295.56283.42250.25252.6275.18295.23
Property, Plant & Equipment
59.9360.1257.7534.5433.2326.9
Long-Term Investments
0.610.582.466.0649.410.72
Other Intangible Assets
4.041.3611.231.191.13
Long-Term Deferred Tax Assets
47.4146.5536.0131.4730.5327.75
Long-Term Deferred Charges
-2.19-0.71.42.11
Other Long-Term Assets
0.850.872.1813.912.334.55
Total Assets
408.4395.08349.64340.52393.26368.39

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
50.6240.9138.8129.1727.4926.93
Accrued Expenses
4.2114.3113.5712.3910.449.5
Short-Term Debt
-4.794.726.464.483.84
Current Portion of Long-Term Debt
32.566.243.256.378.648.37
Current Portion of Leases
1.271.711.881.981.611.82
Current Unearned Revenue
3.977.745.3825.9326.1130.89
Other Current Liabilities
32.7618.1815.0813.5918.544.99
Total Current Liabilities
125.3993.8882.6995.8997.3286.35
Long-Term Debt
34.5835.5539.8727.0425.8833.39
Long-Term Leases
1.661.131.361.832.011.92
Long-Term Unearned Revenue
9.7212.6417.1722.1444.968.63
Other Long-Term Liabilities
0.050.050.190.190.190.19
Total Liabilities
171.4143.25141.29147.08170.3190.47

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
10.810.810.9311.0111.0111.01
Additional Paid-In Capital
28.5845.9159.8671.2871.2871.28
Retained Earnings
248.02233.83168.38142.22156.51121.29
Treasury Stock
-50.42-38.72-30.83-31.09-15.87-25.68
Comprehensive Income & Other
0.030.020.020.020.020.02
Total Common Equity
237251.83208.36193.44222.96177.92
Shareholders' Equity
237251.83208.36193.44222.96177.92
Total Liabilities & Equity
408.4395.08349.64340.52393.26368.39

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
70.0749.4251.0843.6742.6349.33
Net Cash (Debt)
106.23117.81103.45118.89139.79152.55
Net Cash Growth
10.26%13.88%-12.99%-14.95%-8.36%9.86%
Net Cash Per Share
6.136.755.896.647.748.44
Filing Date Shares Outstanding
17.3417.3617.5717.6418.1118.01
Total Common Shares Outstanding
17.3417.3617.5717.6418.1118.01
Working Capital
170.18189.54167.55156.71177.86208.89
Book Value Per Share
13.6714.5111.8610.9712.319.88
Tangible Book Value
232.97250.48207.36192.2221.77176.79
Tangible Book Value Per Share
13.4414.4311.8010.9012.259.82
Land
-37.8636.0429.0429.0422.59
Machinery
-64.1860.6843.2827.8724.32